Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Directorate Change

19 Aug 2020 12:25

RNS Number : 6094W
Aberdeen Latin American Inc Fd Ltd
19 August 2020
 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

Appointment of Non-Executive Director

 

19 August 2020

 

The Board of Aberdeen Latin American Income Fund Limited (the "Company") is pleased to announce the appointment of Howard Myles as an independent non-executive Director of the Company with effect from 1 October 2020. Mr Myles was appointed after a search conducted by an independent recruitment consultancy.

 

Richard Prosser, Chairman of the Company, said: "The Directors are delighted to welcome Howard to the Board. Howard brings a wealth of knowledge in relation to closed-end funds including experience of the Latin American region.

 

He was a partner with Ernst & Young from 2001 to 2007 and was responsible for the Investment Funds Corporate Advisory team having previously been with UBS Warburg. Starting his career as an equity salesman, he then joined Touche Ross & Co in 1975 where he qualified as a chartered accountant. In 1978 he joined W Greenwell & Co. in the corporate broking team and in 1987 moved to SG Warburg Securities where he was involved in a wide range of commercial and industrial transactions in addition to leading Warburg's corporate finance function for investment funds.

 

Howard is currently Senior Independent Director of BBGI SICAV and Audit Committee Chair of Chelverton UK Dividend Trust plc. He is Chairman of JP Morgan Brazil Investment Trust plc, from which he is due to retire on 17 September 2020, and Chairman of Baker Steel Resources Trust Limited."

 

Mr Myles will stand for election as a Director at the Annual General Meeting to be held on or around 10 December 2020.

 

In accordance with paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules, Mr Myles advises that, within the last five years, he stepped down as a non-executive Director of Lazard World Trust Fund in 2019 and Aberdeen Private Equity Fund Limited in 2018.

 

There are no other disclosures required to be made for Mr Myles in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Mr Myles does not hold any interests in any of the Company's shares.

 

 

Aberdeen Standard Capital International Limited

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKKCBBDBKDNFD
Date   Source Headline
22nd Oct 20208:15 amRNSEdison review on Aberdeen Latin American Inc Fund
21st Oct 202012:03 pmRNSNet Asset Value(s)
20th Oct 202011:51 amRNSNet Asset Value(s)
19th Oct 202012:36 pmRNSNet Asset Value(s)
16th Oct 202012:27 pmRNSNet Asset Value(s)
15th Oct 202012:39 pmRNSNet Asset Value(s)
15th Oct 202011:07 amRNSPortfolio disclosure
14th Oct 20203:31 pmRNSHolding(s) in Company
14th Oct 202011:59 amRNSNet Asset Value(s)
13th Oct 202011:10 amRNSNet Asset Value(s)
12th Oct 20201:53 pmRNSGearing disclosure
12th Oct 202012:12 pmRNSNet Asset Value(s)
9th Oct 202011:24 amRNSNet Asset Value(s)
8th Oct 202011:45 amRNSNet Asset Value(s)
7th Oct 202012:59 pmRNSNet Asset Value(s)
6th Oct 20204:11 pmRNSMonth End Net Asset Value(s)
6th Oct 202012:54 pmRNSNet Asset Value(s)
5th Oct 20203:17 pmRNSGearing disclosure
5th Oct 20201:19 pmRNSNet Asset Value(s)
5th Oct 20207:00 amRNSCompliance with Market Abuse Regulation
2nd Oct 202012:32 pmRNSNet Asset Value(s)
30th Sep 202011:50 amRNSNet Asset Value(s)
29th Sep 202012:28 pmRNSNet Asset Value(s)
28th Sep 20202:36 pmRNSGearing disclosure
28th Sep 202012:10 pmRNSNet Asset Value(s)
28th Sep 202011:45 amRNS4th Interim Dividend
25th Sep 20201:53 pmRNSNet Asset Value(s)
24th Sep 202012:13 pmRNSNet Asset Value(s)
23rd Sep 202012:18 pmRNSNet Asset Value(s)
22nd Sep 202012:39 pmRNSNet Asset Value(s)
21st Sep 20201:43 pmRNSGearing disclosure
21st Sep 202012:41 pmRNSNet Asset Value(s)
18th Sep 202011:37 amRNSNet Asset Value(s)
17th Sep 202011:44 amRNSNet Asset Value(s)
16th Sep 202011:53 amRNSNet Asset Value(s)
15th Sep 202011:58 amRNSNet Asset Value(s)
14th Sep 202012:37 pmRNSGearing disclosure
14th Sep 202012:23 pmRNSNet Asset Value(s)
11th Sep 202011:57 amRNSPortfolio disclosures
11th Sep 202011:14 amRNSNet Asset Value(s)
10th Sep 202011:50 amRNSNet Asset Value(s)
9th Sep 202011:23 amRNSNet Asset Value(s)
8th Sep 202011:48 amRNSNet Asset Value(s)
7th Sep 20201:24 pmRNSGearing Disclosure
7th Sep 202012:02 pmRNSNet Asset Value(s)
4th Sep 20201:50 pmRNSMonth End Net Asset Value(s)
4th Sep 202011:11 amRNSNet Asset Value(s)
3rd Sep 202011:28 amRNSNet Asset Value(s)
2nd Sep 20201:08 pmRNSQuarterly Disclosures
2nd Sep 202011:53 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.